EYPT Q2 2018 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$715,000+2.0% YoY

Gross Profit

-$4M-566.4% margin

Operating Income

-$10M-1368.1% margin

Net Income

-$34M-4815.1% margin

EPS (Diluted)

$-6.22

QoQ Revenue Growth

-23.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$974,000

Balance Sheet

Total Assets

$72M

Total Liabilities

$60M

Stockholders' Equity

$12M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$715,000	$701,000	+2.0%
Gross Profit	-$4M	$701,000	-677.7%
Operating Income	-$10M	-$6M	-59.4%
Net Income	-$34M	-$6M	-462.9%